Literature DB >> 1127075

Suppression of renin and aldosterone by small amounts of DOCA in normal man.

R E Shade, C E Grim.   

Abstract

Previous investigators have suggested that low renin hypertension may be due to an unknown mineralocorticoid. This investigation was designed to simulate the effect of an unknown mineralocorticoid by administration of small amounts of desoxycorticosterone acetate (DOCA) in three normal subjects. The response of 2-h upright plasma renin activity (PRA), plasma aldosterone concentration (PA), and urinary aldosterone excretion (UA), as well as extracellular fluid volume, (ECFV) was determined on a high and low salt diet before and during the administration of DOCA for 13 days. After 9 days of DOCA, ECFV increased approximately 2 liters and PRA decreased to levels found in our patients with LRH. PA and UA decreased appropriately as PRA was suppressed. We would expect an unknown mineralocorticoid to have similar effects on the reninangiotension-aldosterone system. Thus, these results would suggest that in LRH the normal levels of PA and UA are inappropriately elevated in relation to the low PRA.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127075     DOI: 10.1210/jcem-40-4-652

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

Review 2.  Evolution of diagnostic criteria for primary aldosteronism: why is it more common in "drug-resistant" hypertension today?

Authors:  Clarence E Grim
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

Review 3.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

4.  Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.

Authors:  A A Taylor; J R Mitchell; F C Bartter; W R Snodgrass; R J McMurtry; J R Gill; R B Franklin
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.